Health News Releases

  • Today May 15
August 18, 2021 11:00
SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have expanded their product line of research reagents for COVID-19 variant analysis to include a mutation connected to the S
August 17, 2021 14:09
Philip Morris International Enters Tender Period with Vectura Shareholders Following Unanimous Recommendation by Vectura Board
Philip Morris International Inc. (PMI) (NYSE: PM) today announced it has published an offer document with U.K.-based Vectura Group plc (Vectura) (LSE: VEC) in connection with the recommended cash offe
August 13, 2021 10:40
Rockley Photonics Announces Successful Closing of Business Combination with SC Health Corp.
Rockley Photonics, Ltd. (“the Company” or “Rockley”), a leading global silicon photonics technology company, today announced the completion of its business combination with SC Health Corp. (“SC Health
August 12, 2021 17:30
SpeeDx Receives Clearance for COVID-19 Diagnostic Test
SpeeDx Pty. Ltd. announced today their PlexPCR® SARS-CoV-2[*] test received clearance from the Australian Therapeutic Goods Administration (TGA). Designed from a database of over 1,000,000 sequences,
Siemens Korea holds ‘8th Smart NC Contest’ online… Recruiting participants from university and high
August 12, 2021 11:51
Siemens Korea Holds ‘8th Smart NC Contest’ Online… Recruiting Participants from University and High School Groups
Siemens Korea (Siemens Ltd. Seoul·SLS) calls for participants until September 1 for the ‘8th Smart NC(Numerical Control) Contest’ officially held on September 2. The Smart NC Contest, which marks i
August 10, 2021 11:20
Lightbeam Health Solutions Announces Partnership with Genetic Testing Company, Ambry Genetics
Lightbeam Health Solutions, the leader in end-to-end population health management solutions and services, is proud to announce their partnership with Ambry Genetics, a Konica Minolta Precision Medicin
August 06, 2021 11:15
Final Results from the Longest Hereditary Angioedema Study of Active Treatment Duration Conducted to Date Support the Sustained Safety and Efficacy of TAKHZYRO® (lanadelumab) Injection for Long-Term Prevention of Hereditary Angioedema Attacks
Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced the publication of the final results from the Phase 3 HELP (Hereditary Angioedema Long-term Prophylaxis) Study™ Op
August 05, 2021 16:30
Vifor Pharma reports strong H1 2021 growth, on track to meet full year guidance[1]
Regulatory News: Vifor Pharma Group reported profitable revenue growth in H1 supported by a strong recovery in Ferinject® / Injectafer® with sales up 22.8% at CER as a result of improved patient ac
August 04, 2021 11:00
Former World Economic Forum Member of the Managing Board Murat Sönmez Joins Avellino’s Board of Directors
Avellino Lab USA, Inc. (Avellino) today announced the appointment of Murat Sönmez to the company’s Board of Directors. Murat is a former World Economic Forum Member of the Managing Board and foundi
Frank Zimmermann, Senior Executive Vice President & CFO of Siemens Korea
August 04, 2021 10:58
Siemens appoints Frank Zimmermann as Senior Executive Vice President and CFO of Siemens Korea
Siemens announced the official appointment of Mr. Frank Zimmermann as Senior Executive Vice President & Chief Financial Officer (CFO) of Siemens Korea (Siemens Ltd. Seoul·SLS) effective August 1, 2021
August 03, 2021 17:22
First half of 2021: Boehringer Ingelheim makes fundamental progress in research and development
In the first half of 2021, Boehringer Ingelheim has supplied more humans and animals worldwide with innovative medicines than ever before. The company’s success is based on its rich R&D portfolio with
August 02, 2021 17:00
Takeda Receives Decision by the Irish Tax Appeals Commission Relating to Tax Assessment on Break Fee Shire Received from AbbVie
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the receipt of a decision by the Irish Tax Appeals Commission on July 30, 2021 (IST) to uphold the Irish Revenue Co
August 02, 2021 15:50
NIH Advances ACTIV-5/BET-B Trial Evaluating Lenzilumab from a Phase 2 Exploratory Study to a Phase 2/3 Study for the Treatment of COVID-19
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company developing a first-in-class GM-CSF neutralizing antibody to prevent and treat an immune hyper-response called ‘
August 02, 2021 13:40
ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results from Two on-going Phase 2a Studies in Chronic Hepatitis B Patients
ENYO Pharma (ENYO), a private clinical stage biotechnology company developing innovative drug candidates, today announced positive proof of concept data from Study EYP001-203 of Vonafexor in combinati
August 02, 2021 13:30
Takeda Delivers Solid First Quarter FY2021 Results, Positioning Company to Accelerate Topline Growth and Continued Pipeline Progress
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced financial results for the first quarter of fiscal year 2021 (period ended June 30, 2021). Based on the solid firs
July 30, 2021 15:30
Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (Takeda) and Frazier Healthcare Partners (Frazier) today announced a collaboration to launch HilleVax, Inc. (HilleVax), a biopharmaceutical co
July 30, 2021 13:20
Prokarium Appoints Uz Stammberger as Chief Medical Officer to Drive Clinical Development in Oncology
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Uz Stammberger, MD, as Chief Medical Officer. In the role, Dr. Stamm
July 29, 2021 15:30
ENYO Pharma Announces Positive Vonafexor (EYP001) Results for the LIVIFY Phase 2a Study in F2-F3 NASH Patients over 12 weeks
ENYO Pharma (ENYO), a private clinical stage biotechnology company developing innovative drug candidates, today announced that Vonafexor met the primary and several secondary endpoints in the LIVIFY c
July 29, 2021 11:11
U.S. Food and Drug Administration Grants Breakthrough Therapy Designation to Takeda’s Investigational Compound, TAK-994, an Oral Orexin Agonist in Clinical Development for Narcolepsy Type 1 (NT1)
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) to TAK-994,[1] its
July 28, 2021 12:10
Prokarium Appoints Kristen Albright as Chief Executive Officer
Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, today announced the appointment of Kristen Albright, PharmD, as Chief Executive Officer. Dr. Albrigh
Deargen signed an agreement with Sookmyung Women’s University Research & Business Development Founda
July 28, 2021 09:49
Deargen Signs Agreement With Sookmyung Women’s University Research & Business Development Foundation for Licensing NASH Biomarker Technologies
Deargen (President: Kilsoo Kang), an artificial intelligence (AI)-powered drug discovery and development company, announced that it has signed an agreement with Sookmyung Women’s University Research &
July 27, 2021 14:00
Dr. Revati Shreeniwas Joins ImmunoMet Therapeutics as Chief Medical Officer
ImmunoMet Therapeutics, Inc., a clinical stage biotechnology company targeting metabolism to develop novel anti-fibrotic and anti-cancer therapies, today announced that Dr. Revati Shreeniwas has joine
July 27, 2021 13:45
SpeeDx Launch Solution for SARS-CoV-2 Variant Analysis
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have launched a new product line of research reagents to support reflex variant analysis for circulating SARS-CoV-2 variants
July 27, 2021 10:20
Wyss Center Partners With Artiria Medical to Accelerate a Novel Therapy for Cerebral Vasospasm
The Wyss Center and Artiria Medical today announced a new partnership to accelerate the translation of a novel technology that has the potential to reduce deaths and improve quality of life for stroke
Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth
July 26, 2021 16:11
Women in India are the first in the world to receive new heat-stable carbetocin formulation to prevent excessive bleeding after childbirth
After nearly a decade of public-private collaboration, Ferring Pharmaceuticals today announces the first use of heat-stable carbetocin (Carbetocin Ferring) for the prevention of excessive bleeding aft
25 per page50 per page75 per page100 per page